PharmaAConsultancy ApS: Financial statements 2024
CVR: 42788341
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PharmaAConsultancy ApS (CVR 42788341) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 488,332 and a net result of DKK -119,168 compared with DKK 135,673 the year before. That is an increase of 121.7% compared with the year before. The profit margin was -24.4%. Equity in the 2024 report amounted to DKK 88,798. The solvency ratio was 31.8%.
- Revenue
- DKK 488,332
- Gross Profit
- DKK 296,565
- Profit/Loss
- DKK -119,168
- Equity
- DKK 88,798
- Total Assets
- DKK 278,993
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 488K | 297K | -119K | 89K | - |
| 2023 | 220K | 178K | 136K | 208K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PharmaAConsultancy ApS has published its annual report for 2023. Revenue came to DKK 220,250, and the net result was DKK 135,673.
About PharmaAConsultancy ApS
PharmaAConsultancy ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2021. The company is registered under the industry Anden undervisning i.a.n.. The management consists of Hashmatullah Nasimi and Khalid Essam Abdel-Raouf Amar. The company is owned by Khalid Essam Abdel-Raouf Amar and Hashmatullah Nasimi. The company has 2 employees (2025). In 2025, the company reported revenue of DKK 59,301 and a net result of DKK -81,144 compared with DKK -119,168 the year before. Equity in the 2025 report amounted to DKK 7,542.